Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic, mutational, and immunologic analysis of CD90 in pan-cancer and validation of DHDK as a drug candidate.

Naunyn-Schmiedeberg's archives of pharmacology - 1 Feb 2026

Zhao Jingtao, Wang Yuqing, Zhang Fangyu, Wang Xinyue, Meng Lin, Hong Jing, Guo Dingjia, Di Xin, Zhao Yunli

Abstract excerpt

The CD90 gene encodes a cell surface glycoprotein that plays an important role in the development and progression of cancer. Regarding CD90 gene, pan-cancer analysis of investigating the correlation between CD90 and immune filtration, patients prognosis is still unclear. TCGA, GTEx, TIMER 2.0, GEPIA2 databases and web tool were used for analyzing CD90 gene impacts among multiple cancer types. The data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Databases, Genetic

Share to Molecular Docking Simulation

Share to Neoplasms

Share to Prognosis

Share to Thy-1 Antigens

Source

Identifiers

PMID: 41042271
DOI: 10.1007/s00210-025-04598-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic, mutational, and immunologic analysis of CD90 in pan-cancer and validation of DHDK as a drug candidate.PMID 41042271Read ↗

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against CancerSemantic proximity Read ↗

High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumorsSemantic proximity Read ↗

HSP90 and the cancer transcriptome: a comprehensive review of inhibitors and mechanistic insightsSemantic proximity Read ↗

Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.Semantic proximity Read ↗

High expression of HSP90 is associated with poor prognosis in patients with colorectal cancerSemantic proximity Read ↗

GPCR Inhibition in Treating LymphomaSemantic proximity Read ↗

Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells.Semantic proximity Read ↗

From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in CancerSemantic proximity Read ↗

Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening.Semantic proximity Read ↗

CD90 Is Regulated by NOTCH1 and Hallmarks a More Aggressive Intrahepatic Cholangiocarcinoma PhenotypeSemantic proximity Read ↗

HSP90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical centerSemantic proximity Read ↗

Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.